They help you stay on track, adjust your plan when needed, and encourage you to keep going
with dual 503A/503B licensing and massive GLP-1 production capacity Key Strengths: Dual 503A and 503B registered facility enabling both patient-specific and bulk compounding at scale One of the first pharmacies to offer compounded semaglutide with full potency verification and published COAs State-of-the-art 140,000 sq ft FDA-registered facility in Houston with dedicated cleanroom suites Extensive tirzepatide and semaglutide formulations including sublingual and injectable options Notable: Empower processes over 100,000 semaglutide prescriptions monthly, making them the single largest volume compounder of GLP-1 therapies in the nation
Talk to a qualified clinician before making health decisions
Such designs are not representative of the clinical scenario, in which patients present with established, symptomatic disease
This product requires aValid prescription
4 It is simply the measured pace of psychological adaptation, which has always been slower than biology